Single Center Observational Study to Evaluate the Clinical Outcome of Patients with Bioabsorbable Vascular Scaffold (BVS, ABSORB® Abbot Vascular) after standard PCI Procedure.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019947

Enrollment

150

Registered

2020-12-21

Start date

2020-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20-I25

Interventions

Group 1: Patients treated with a BioVascucular Scaffold (BVS) as part of a PCI.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Patient received a BVS at the Hegau-Bodensee Clinic between 2013 and 2017, (2) Signed informed consent and privacy policy

Exclusion criteria

Exclusion criteria: (1) Patient age < 18 years, (2) Patient is not able to write and understand German

Design outcomes

Primary

Measure	Time frame
combined endpoint of Cardiac Death (CD), Myocardial Infarction (MI), Target Lesion Revascularization (TLR), Target Vessel Revascularization (TVR), Stent Thrombosis (ST)	—

Secondary

Measure	Time frame
Quality of life measured by EQ-5D-5L	—

Countries

Germany

Contacts

Public ContactMarc Kollum

Hegau-Bodensee Kliniken Singen

marc.kollum@glkn.de07731 89 2600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026